Article
Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy.
Acta pharmacologica Sinica - 1 Apr 2025
Zhang Bu-Chun, Zhu Wen-Ya, Wang Sheng-Nan, Zhu Meng-Meng, Ma Hui, Dong Liang, Yang Xiao-Xiao, Ma Chuan-Rui, Ma Li-Kun, Chen Yuan-Li
Abstract excerpt
Vascular smooth muscle cell (VSMC) phenotype transformation significantly contributes to vascular intimal hyperplasia. However, effective preventive and therapeutic measures are lacking. Colchicine, a binary alkaloid derived from Colchicum autumnale, is traditionally used for treating inflammatory diseases. Its role in neointima formation is not fully understood. Here, we investigated the role of colchicine in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
